Copeland Capital Management, LLC Viatris Inc Transaction History

Copeland Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$9.2 - $12.26 $3,974 - $5,296	-432 Reduced 70.02%	185 $2,000
Q3 2021 Jan 18, 2022	BUY	$13.25 - $15.13 $8,175 - $9,335	617 New	617 $8,000
Q3 2021 Oct 20, 2021	SELL	$13.25 - $15.13 $8,175 - $9,335	-617 Closed	0 $0
Q2 2021 Jan 18, 2022	BUY	$12.97 - $16.15 $8,002 - $9,964	617 New	617 $9,000
Q2 2021 Jul 19, 2021	SELL	$12.97 - $16.15 $8,002 - $9,964	-617 Closed	0 $0
Q1 2021 Jan 18, 2022	BUY	$13.59 - $18.54 $8,385 - $11,439	617 New	617 $9,000
Q1 2021 Apr 26, 2021	SELL	$13.59 - $18.54 $8,385 - $11,439	-617 Closed	0 $0
Q4 2020 Jan 18, 2022	BUY	$14.3 - $18.74 $8,823 - $11,562	617 New	617 $12,000

1,129

989M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $10.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Copeland Capital Management, LLC with notifications on news.